Comment: Current Options in the Management of Olanzapine-Associated Weight Gain

Abstract

Get full access to this article

View all access options for this article.

References

Hester

Thrower

. Current options in the management of olanzapine-associated weight gain. Ann Pharmacother 2005; 39:302–10. DOI 10.1345/aph.1D423

Schneider

Dagerman

. Psychosis of Alzheimer's disease: Clinical characteristics and history. J Psychiatr Res 2004; 38:105–11.

Wang

Yang

Lin

Chen

Chwang

Liu

. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol 2004; 251:314–20.

Volpato

Romagnoni

Soattin

Ble

Leoci

Bollini

. Body mass index, body cell mass, and 4-year all-cause mortality risk in older nursing home residents. J Am Geriatr Soc 2004; 52:886–91.

Fabiny

Kiel

. Assessing and treating weight loss in nursing home patients. Clin Geriatr Med 1997; 13:737–51.

White

McConnell

Bales

Kuchibhatla

. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects. J Am Med Dir Assoc 2004; 5:89–97.

Raji

Brady

. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother 2001; 35:1024–7. DOI 10.1345/aph.10371